120 related articles for article (PubMed ID: 20228159)
1. Changing patterns of secondary preventive medication among newly diagnosed coronary heart disease patients with diabetes in Finland: a register-based study.
Vehko T; Manderbacka K; Arffman M; Sund R; Reunanen A; Keskimäki I
Scand J Public Health; 2010 May; 38(3):317-24. PubMed ID: 20228159
[TBL] [Abstract][Full Text] [Related]
2. Use of secondary preventive medications after the first attack of acute coronary syndrome.
Salomaa V; Pääkkönen R; Hämäläinen H; Niemi M; Klaukka T
Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):386-91. PubMed ID: 17568237
[TBL] [Abstract][Full Text] [Related]
3. [Can Danish health care registries provide data for specific drug-related hospital admissions in type 2 diabetes?].
Thomsen LA; Gundgaard J; Søndergaard B; Melander A; Sørensen J
Ugeskr Laeger; 2007 Aug; 169(33):2637-42. PubMed ID: 17725913
[TBL] [Abstract][Full Text] [Related]
4. Gender differences in the treatment and secondary prevention of CHD at population level.
Kattainen A; Salomaa V; Jula A; Antero Kesäniemi Y; Kukkonen-Harjula K; Kähönen M; Majahalme S; Moilanen L; Nieminen MS; Aromaa A; Reunanen A
Scand Cardiovasc J; 2005 Dec; 39(6):327-33. PubMed ID: 16352484
[TBL] [Abstract][Full Text] [Related]
5. Increasing resources effected equity in access to revascularizations for patients with diabetes.
Vehko T; Manderbacka K; Arffman M; Reunanen A; Keskimäki I
Scand Cardiovasc J; 2010 Aug; 44(4):237-44. PubMed ID: 20586656
[TBL] [Abstract][Full Text] [Related]
6. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes.
Winkelmayer WC; Fischer MA; Schneeweiss S; Wang PS; Levin R; Avorn J
Am J Kidney Dis; 2005 Dec; 46(6):1080-7. PubMed ID: 16310574
[TBL] [Abstract][Full Text] [Related]
7. Trends in antihypertensive and lipid-lowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?
Gulliford MC; Charlton J; Latinovic R
J Hum Hypertens; 2005 Feb; 19(2):111-7. PubMed ID: 15361893
[TBL] [Abstract][Full Text] [Related]
8. [Drug therapy of coronary heart disease--are therapeutic guidelines being paid attention to?].
Böger GI; Hoopmann M; Busse R; Budinger M; Welte T; Böger RH
Z Kardiol; 2003 Jun; 92(6):466-75. PubMed ID: 12819995
[TBL] [Abstract][Full Text] [Related]
9. Trends in the use of evidence-based treatments for coronary artery disease among women and the elderly: findings from the get with the guidelines quality-improvement program.
Lewis WR; Ellrodt AG; Peterson E; Hernandez AF; LaBresh KA; Cannon CP; Pan W; Fonarow GC
Circ Cardiovasc Qual Outcomes; 2009 Nov; 2(6):633-41. PubMed ID: 20031902
[TBL] [Abstract][Full Text] [Related]
10. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F;
Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
[TBL] [Abstract][Full Text] [Related]
11. Coronary heart disease among diabetic and nondiabetic people - socioeconomic differences in incidence, prognosis and mortality.
Forssas EH; Keskimäki IT; Reunanen AR; Koskinen SV
J Diabetes Complications; 2008; 22(1):10-7. PubMed ID: 18191072
[TBL] [Abstract][Full Text] [Related]
12. [Health care quality: medication and prevention in patients with and without coronary heart disease].
Baberg HT; Yazar A; Brechmann T; Grewe P; Kugler J; De Zeeuw J; Bojara W; Lawo T; Mügge A
Med Klin (Munich); 2004 Jan; 99(1):1-6. PubMed ID: 14716479
[TBL] [Abstract][Full Text] [Related]
13. Socioeconomic position and secondary preventive therapy after an AMI.
Ohlsson H; Rosvall M; Hansen O; Chaix B; Merlo J
Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):358-66. PubMed ID: 20087850
[TBL] [Abstract][Full Text] [Related]
14. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence.
Simpson E; Beck C; Richard H; Eisenberg MJ; Pilote L
Am Heart J; 2003 Mar; 145(3):438-44. PubMed ID: 12660666
[TBL] [Abstract][Full Text] [Related]
15. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
[TBL] [Abstract][Full Text] [Related]
16. Positive change in the utilization of antihypertensive and lipid-lowering drugs among adult CHD patients in Finland: results from a large national database between 2000 and 2006.
Ahola TL; Kantola IM; Puukka P; Kattainen A; Klaukka T; Reunanen A; Jula AM
Eur J Cardiovasc Prev Rehabil; 2010 Aug; 17(4):477-85. PubMed ID: 20220527
[TBL] [Abstract][Full Text] [Related]
17. Discharge prescriptions following admission for acute myocardial infarction at tertiary care and community hospitals in Quebec.
Beck CA; Lauzon C; Eisenberg MJ; Huynh T; Dion D; Roux R; Racine N; Carignan S; Diodati JG; Charbonneau F; Lévesque C; Pouliot J J; Pilote L L
Can J Cardiol; 2001 Jan; 17(1):33-40. PubMed ID: 11173312
[TBL] [Abstract][Full Text] [Related]
18. Use and cost of branded and generic drugs in patients with coronary heart disease--results from a prospective survey of 1008 patients in two London hospitals.
Corp EV; Antoniou S; Wright PG; Khachi H; Vercaeren S; Wald DS
QJM; 2009 Dec; 102(12):843-9. PubMed ID: 19828644
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
Grothusen A; Divchev D; Luchtefeld M; Schieffer B
Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
[TBL] [Abstract][Full Text] [Related]
20. Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR).
Gudbjörnsdottir S; Eeg-Olofsson K; Cederholm J; Zethelius B; Eliasson B; Nilsson PM;
Diabet Med; 2009 Jan; 26(1):53-60. PubMed ID: 19125761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
